Failure of allopurinol to improve left ventricular stroke work after cardiopulmonary bypass surgery

被引:16
作者
Coetzee, A [1 ]
Roussouw, G [1 ]
Macgregor, L [1 ]
机构
[1] UNIV STELLENBOSCH,SCH MED,DEPT CARDIOTHORAC SURG,ZA-7505 TYGERBERG,SOUTH AFRICA
关键词
allopurinol; reperfusion injury; coronary artery bypass surgery;
D O I
10.1016/S1053-0770(96)80141-8
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: This study examined the effects of allopurinol on global left ventricular function after coronary artery bypass surgery. Design: A randomized prospective partially blinded study in 52 patients undergoing elective coronary artery bypass surgery. Setting: Conducted in a university-affiliate tertiary care facility. Interventions: Participants received 400 mg of allopurinol 18 hours and 400 mg of allopurinol orally 3 hours before surgery or no allopurinol. Patients then received a standard anesthetic technique consisting of target-controlled opiate infusion and inhalation anesthesia. Coronary artery bypass was performed using moderate hypothermia and oxygenated crystalloid cardioplegia. Measurements and Main Results: Global left ventricular function was assessed by means of left ventricular stroke work index (LVSWI) calculated before and after induction of anesthesia and after cardiopulmonary bypass at 15 minutes, 6, 12 and 24 hours. There was no difference in the LVSWI before or after surgery when the two groups were compared. Conclusions: In this population sample, the use of preoperative allopurinol did not result in improved left ventricular stroke work after coronary artery bypass surgery. Copyright (C) 1996 by W.B. Saunders Company
引用
收藏
页码:627 / 633
页数:7
相关论文
共 36 条
[21]   INFLUENCE OF PROPRANOLOL ISOMERS AND ATENOLOL ON MYOCARDIAL CYCLIC-AMP, HIGH-ENERGY PHOSPHATES AND VULNERABILITY TO FIBRILLATION AFTER CORONARY-ARTERY LIGATION IN THE ISOLATED RAT-HEART [J].
LUBBE, WF ;
MULLER, CA ;
WORTHINGTON, M ;
MCFADYEN, EL ;
OPIE, LH .
CARDIOVASCULAR RESEARCH, 1981, 15 (12) :690-699
[22]   EFFECTS OF PROPRANOLOL ON MYOCARDIAL DAMAGE RESULTING FROM CORONARY-ARTERY OCCLUSION FOLLOWED BY REPERFUSION [J].
MIYAZAWA, K ;
FUKUYAMA, H ;
KOMATSU, E ;
YAMAGUCHI, I .
AMERICAN HEART JOURNAL, 1986, 111 (03) :519-524
[23]   CLINICAL PHARMACOKINETICS OF ALLOPURINOL [J].
MURRELL, GAC ;
RAPEPORT, WG .
CLINICAL PHARMACOKINETICS, 1986, 11 (05) :343-353
[24]   N-2-MERCAPTOPROPIONYLGLYCINE IMPROVES RECOVERY OF MYOCARDIAL-FUNCTION AFTER REVERSIBLE REGIONAL ISCHEMIA [J].
MYERS, ML ;
BOLLI, R ;
LEKICH, RF ;
HARTLEY, CJ ;
ROBERTS, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (05) :1161-1168
[25]   PROTECTIVE EFFECT OF PRETREATMENT WITH VERAPAMIL, NIFEDIPINE AND PROPRANOLOL ON MITOCHONDRIAL-FUNCTION IN THE ISCHEMIC AND REPERFUSED MYOCARDIUM [J].
NAYLER, WG ;
FERRARI, R ;
WILLIAMS, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1980, 46 (02) :242-248
[26]   PHARMACOLOGICAL PROTECTION OF MITOCHONDRIAL-FUNCTION IN HYPOXIC HEART-MUSCLE - EFFECT OF VERAPAMIL, PROPRANOLOL, AND METHYLPREDNISOLONE [J].
NAYLER, WG ;
FASSOLD, E ;
YEPEZ, C .
CARDIOVASCULAR RESEARCH, 1978, 12 (03) :152-161
[28]  
OPIE LH, 1987, DRUGS HEART, P5
[29]  
PARKS DA, 1982, GASTROENTEROLOGY, V82, P9
[30]   ATTENUATION OF MYOCARDIAL ACIDOSIS BY PROPRANOLOL DURING ISCHEMIC ARREST AND REPERFUSION - EVIDENCE WITH P-31 NUCLEAR MAGNETIC-RESONANCE [J].
PIEPER, GM ;
TODD, GL ;
WU, ST ;
SALHANY, JM ;
CLAYTON, FC ;
ELIOT, RS .
CARDIOVASCULAR RESEARCH, 1980, 14 (11) :646-653